Clinical Decision Support (CDS) Market, By Product (Diagnostic CDS and Therapeutics CDS), By Application (Drug Allergy Alert, Drug-Drug Interaction, Clinical Reminder, Clinical Guideline, and Drug Dosing Support), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI341719 | Publish Date: May 2024 | No. of Pages: 170

Global Clinical Decision Support Market Trends

Growing Utilization of Medical Information Technology

Clinical Decision Support (CDS) Market growth is primarily being driven by government regulations, medical errors, prescription errors, and large-scale data platforms. The medical industry's increasing need for clinical decision support systems is primarily due to the expanding adoption of healthcare technologies. Utilizing these technologies can help patients make better decisions, monitor their safety, and receive care more efficiently.

For example, a study of 22 research conducted for the Centers for Disease Control and Prevention (CDC) report reveals that employing clinical dashboards or CDS systems might enhance patient outcomes, make processes more efficient, and provide physicians with rapid access to patient information. Building on the foundation of an EHR, CDS is a health information technology that provides healthcare professionals with both generic and patient-specific data to enhance patient care.

Furthermore, based on compelling evidence of efficacy for both the general population and those at high risk for HIV infection, a 2021 systematic review study from The Community Preventive Services Task Force demonstrated that the implementation of CDS systems boosts HIV screening. Overall, it has been demonstrated that CDS systems enhance health care process metrics including diagnostic precision, decision-making, and the elimination of needless testing in a variety of contexts. In consequence, this research encourages the expansion of the clinical decision support (CDS) market.